← Back to Clinical Trials
Recruiting NCT07497100

NCT07497100 Relationship Between Upper Limb Function and Participation in Hemiplegic cp

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07497100
Status Recruiting
Phase
Sponsor Cairo University
Condition Quality of Upper Limb Function
Study Type OBSERVATIONAL
Enrollment 72 participants
Start Date 2026-01-01
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 8 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 72 participants in total. It began in 2026-01-01 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will be conducted to * Assess quality of upper limb function in children with hemiplegic CP. * Assess participation activities of children with hemiplegic CP. * Assess the relationship between quality of upper limb function and participation activities of children with hemiplegic CP.

Eligibility Criteria

Inclusion Criteria: * Children diagnosed with hemiplegic cerebral palsy. * Both genders will be included. * Children's age will be ranging from 5 to 8 years. * The degree of spasticity in affected upper limb ranges from grade 1, 1+ and 2 according to Modified Ashworth Scale. * Children are able to understand and respond to simple instructions. * Children in inclusion education system. * Parents are of nearly the same socioeconomic level and must have at least an average level of education. Exclusion Criteria: * Children will be excluded in the presence of the following: * Severe visual, auditory or perceptual impairment that interfere with the evaluation program. * Botulinum toxin injection in upper limb or recent orthopedic surgery within last 6 months (Alkan and Bingol,2021). * Fixed deformities in the affected upper limb. Significant mental or psychological problems that interfere with understanding instructions.

Contact & Investigator

Central Contact

Mourine Mounir Amir

✉ mourine.mounir15@gmail.com

📞 01274996490

Principal Investigator

Hoda AbdelAzim El talawy, professor

PRINCIPAL INVESTIGATOR

Hoda_eltalawy@hotmail.com

Frequently Asked Questions

Who can join the NCT07497100 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 8 Years, studying Quality of Upper Limb Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07497100 currently recruiting?

Yes, NCT07497100 is actively recruiting participants. Contact the research team at mourine.mounir15@gmail.com for enrollment information.

Where is the NCT07497100 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07497100 clinical trial?

NCT07497100 is sponsored by Cairo University. The principal investigator is Hoda AbdelAzim El talawy, professor at Hoda_eltalawy@hotmail.com. The trial plans to enroll 72 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology